Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-03-31
MYOSMyos Rens Technology Inc.Mannello JosephCEO, 10%P - Purchase$0.00+16,5291,387,557+1%+$0
2020-03-31
MYOSMyos Rens Technology Inc.Dewey Christopher CDirP - Purchase$0.00+6,611328,982+2%+$0
2020-03-31
MYOSMyos Rens Technology Inc.Ponte Andrew JoelDirP - Purchase$0.00+3,30697,499+4%+$0
M
2020-04-02
TFFPTff Pharmaceuticals, Inc.Fletcher Aaron G.L.DirP - Purchase$4.04+23,50069,419+51%+$94,873
M
2020-03-27
NLTXNeoleukin Therapeutics, Inc.Redmile Group, LLC10%P - Purchase$10.35+194,3004,041,211+5%+$2,011,281
M
2020-04-01
NLTXNeoleukin Therapeutics, Inc.Redmile Group, LLC10%S - Sale$11.19-19,6684,041,2110%-$220,155
M
2020-04-02
SPPISpectrum Pharmaceuticals IncLebel FrancoisChief Medical OfficerS - Sale$2.18-2,082309,596-1%-$4,529
2020-04-02
MYOKMyokardia, Inc.Gianakakos AnastasiosPres, CEOS - Sale$44.77-2,500665,3690%-$111,917
2020-04-02
MRUSMerus N.V.Throsby MarkEVP, Chief Scientific OfficerS - Sale$10.93-36844,495-1%-$4,022
2020-04-03
LLYEli Lilly & CoLilly Endowment Inc10%S - Sale$143.19-26,723113,078,5810%-$3,826,493
2020-04-03
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$1.15+50,000221,517,8220%+$57,592
2020-04-01
STMLStemline Therapeutics IncGionco DavidChief Accounting OfficerS - Sale$4.79-11,524282,878-4%-$55,200
2020-04-01
FOLDAmicus Therapeutics, Inc.Crowley John FCOB, CEOS - Sale$9.08-9,7551,014,591-1%-$88,608
D
2020-04-01
FOLDAmicus Therapeutics, Inc.Campbell Bradley LCOOS - Sale+OE$9.09-15,003362,858-4%-$136,310
D
2020-04-01
FTSVForty Seven, Inc.Takimoto Chris HChief Medical OfficerS - Sale+OE$95.42-79,1953,906-95%-$7,556,787
D
2020-04-01
FTSVForty Seven, Inc.Rhoads Ann DCFOS - Sale+OE$95.42-1,92437,414-5%-$183,598
D
2020-04-01
FTSVForty Seven, Inc.McCamish Mark AnthonyPres, CEOS - Sale+OE$95.42-32,5774,595-88%-$3,108,504
D
2020-04-01
KRTXKaruna Therapeutics, Inc.Miller Andrew CraigCOOS - Sale+OE$64.37-25,0000-100%-$1,609,250
D
2020-04-01
KRTXKaruna Therapeutics, Inc.Brannan Stephen K.Chief Medical OfficerS - Sale+OE$67.36-7,7287,500-51%-$520,558
DM
2020-04-02
REGNRegeneron Pharmaceuticals, Inc.Landry Robert EEVP Finance CFOS - Sale+OE$494.49-78824,545-3%-$389,659
M
2020-04-01
REGNRegeneron Pharmaceuticals, Inc.Landry Robert EEVP Finance CFOS - Sale$488.90-1,84825,161-7%-$903,483
2020-04-02
PBYIPuma Biotechnology, Inc.Bryce Richard PaulSEE REMARKSS - Sale$7.37-9177,9210%-$671
2020-04-02
PBYIPuma Biotechnology, Inc.Auerbach Alan HPres, CEO, 10%S - Sale$7.38-3474,307,5340%-$2,563
2020-04-01
PHATPhathom Pharmaceuticals, Inc.Ra Capital Management, L.P.10%P - Purchase$24.86+117,6003,825,008+3%+$2,923,642
D
2020-04-02
ALKSAlkermes Plc.Pops Richard FDir, CEO, Alkermes plcS - Sale+OE$13.79-50,000759,094-6%-$689,500
2020-04-01
BBIOBridgebio Pharma, Inc.Henderson Michael ThomasSee RemarksS - Sale$26.94-2,585167,727-2%-$69,629
D
2020-04-01
STSASatsuma Pharmaceuticals, Inc.Albrecht DetlefChief Medical OfficerS - Sale+OE$20.25-20020,012-1%-$4,049
2020-04-01
BBIOBridgebio Pharma, Inc.Stephenson Brian CSee RemarksS - Sale$26.61-7,200330,316-2%-$191,610
M
2020-04-01
BBIOBridgebio Pharma, Inc.Kumar NeilCEO, PresS - Sale$26.02-77,8958,180,888-1%-$2,026,466
D
2020-04-01
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasDirS - Sale+OE$37.57-75,0000-100%-$2,817,558
D
2020-04-02
REGNRegeneron Pharmaceuticals, Inc.Larosa Joseph JEVP GC, SecretS - Sale+OE$489.98-6,79714,693-32%-$3,330,406
D
2020-04-01
REGNRegeneron Pharmaceuticals, Inc.Fenimore Christopher R.VP ControllerS - Sale+OE$488.41-1,20019,188-6%-$586,096
M
2020-04-01
MYOVMyovant Sciences Ltd.Sumitomo Chemical Co., Ltd.10%P - Purchase$7.60+140,00046,928,6040%+$1,063,384
M
2020-04-01
EMMAEmmaus Life Sciences, Inc.Niihara YutakaCOB, CEO, 10%P - Purchase$1.26+30,80010,717,8370%+$38,784
2020-04-02
LLYEli Lilly & CoLilly Endowment Inc10%S - Sale$140.78-166,038113,105,3040%-$23,374,654
2020-04-02
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$1.16+500,000221,467,8220%+$581,185
2020-03-31
AMARAmarillo Biosciences IncChen Stephen TPres,COB,CEO,CFO, 10%P - Purchase$0.25+2007,215,4560%+$50
2020-03-31
EMMAEmmaus Life Sciences, Inc.Niihara YutakaCOB, CEO, 10%P - Purchase$1.21+13,20010,687,0370%+$15,972
2020-04-01
BMRNBiomarin Pharmaceutical IncAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$82.00-1,53765,471-2%-$126,034
M
2020-03-31
SPPISpectrum Pharmaceuticals IncTurgeon Joseph W.CEO, PresS - Sale$2.28-6,561692,672-1%-$14,952
M
2020-03-31
SPPISpectrum Pharmaceuticals IncRiga Thomas JEVP, COO, CCOS - Sale$2.28-2,792433,783-1%-$6,373
D
2020-04-01
BCELAtreca, Inc.Greenberg Norman MichaelChief Scientific OfficerS - Sale+OE$15.21-2,0000-100%-$30,422
M
2020-03-31
SPPISpectrum Pharmaceuticals IncMcGahan Keith MGCS - Sale$2.27-3,253292,218-1%-$7,395
M
2020-03-31
SPPISpectrum Pharmaceuticals IncGustafson Kurt AEVP, CFOS - Sale$2.28-7,461372,670-2%-$16,980
M
2020-03-31
NGMNgm Biopharmaceuticals IncSvennilson PeterDir, 10%P - Purchase$12.40+250,98417,476,061+1%+$3,111,021
M
2020-03-31
NGMNgm Biopharmaceuticals IncGoeddel David VDir, 10%P - Purchase$12.40+250,98417,646,061+1%+$3,111,021
M
2020-03-31
NGMNgm Biopharmaceuticals IncColumn Group L P10%P - Purchase$12.40+250,98417,471,061+1%+$3,111,021
M
2020-03-31
NGMNgm Biopharmaceuticals IncColumn Group L P10%P - Purchase$12.40+250,98417,471,061+1%+$3,111,021
2020-04-01
AMPHAmphastar Pharmaceuticals, Inc.Petersen Floyd F.DirS - Sale$14.36-50072,142-1%-$7,181
D
2020-04-02
IMGNImmunogen, Inc.Foster David GVP-Fin., Prin. Acctg. OfficerS - Sale+OE$3.43-5,44821,382-20%-$18,687
DM
2019-05-31
SNSSSunesis Pharmaceuticals IncQuinn William P.See RemarksP - Purchase$0.51+12,000127,697+10%+$6,070
2020-04-01
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$1.23+643,549220,967,8220%+$793,012
M
2020-03-30
REGNRegeneron Pharmaceuticals, Inc.Ryan Arthur FDirS - Sale$475.27-20028,943-1%-$95,054
M
2020-03-30
ATHXAthersys, Inc / NewCampbell Laura KSenior Vice Pres FinanceS - Sale$3.34-234,306371,628-39%-$782,586
M
2020-03-31
RYTMRhythm Pharmaceuticals, Inc.Foley ToddDirS - Sale$15.13-34,5702,324,893-1%-$523,153
M
2020-03-30
EMMAEmmaus Life Sciences, Inc.Lee Willis CVice COB, COOP - Purchase$1.26+4,500324,385+1%+$5,665
2020-03-31
LLYEli Lilly & CoLilly Endowment Inc10%S - Sale$140.07-38,962113,271,3420%-$5,457,474
2020-03-30
TYMETyme Technologies, Inc.Demurjian Michael10%S - Sale$1.05-20,00023,958,5460%-$20,906
M
2020-03-30
MYOVMyovant Sciences Ltd.Sumitomo Chemical Co., Ltd.10%P - Purchase$7.81+140,00046,788,6040%+$1,093,750
AM
2020-03-13
ENZNEnzon Pharmaceuticals, Inc.Couchman Jonathan10%P - Purchase$0.14+652,7237,345,162+10%+$91,283
M
2020-03-27
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$2.37+111,91429,400,9610%+$265,346
M
2020-03-27
PHATPhathom Pharmaceuticals, Inc.Ra Capital Management, L.P.10%P - Purchase$24.58+60,6003,707,408+2%+$1,489,264
D
2020-03-30
HZNPHorizon Therapeutics Public Ltd CoMoze BarryEVP, Chief Admin. OfficerS - Sale+OE$28.18-2,106166,291-1%-$59,347
D
2020-03-27
ARMPArmata Pharmaceuticals, Inc.Innoviva, Inc.10%P - Purchase$2.87+7,717,6618,710,800+777%+$22,149,687
D
2019-07-23
RZLTRezolute, Inc.Handok, Inc.10%P - Purchase$0.29+34,482,75891,300,933+61%+$10,000,000
D
2020-03-30
ASMBAssembly Biosciences, Inc.Papkoff Jacqueline SybilSVP-CSO MicrobiomeS - Sale+OE$14.22-1,25438,661-3%-$17,831
D
2020-03-31
ASMBAssembly Biosciences, Inc.Colonno Richard JamesEVP, CSO, Virology OpsS - Sale+OE$15.04-7,812137,009-5%-$117,524
2020-03-30
LLYEli Lilly & CoLilly Endowment Inc10%S - Sale$139.11-210,000113,310,3040%-$29,213,559
2020-03-30
LLYEli Lilly & CoFry Stephen FSVP, HR, DiversityS - Sale$134.30-14,657107,591-12%-$1,968,434
2020-03-30
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$1.35+161,968220,324,2730%+$218,037
M
2020-03-26
EMMAEmmaus Life Sciences, Inc.Niihara YutakaCOB, CEO, 10%P - Purchase$1.11+19,20010,673,8370%+$21,364
M
2020-03-13
AMARAmarillo Biosciences IncChen Stephen TPres,COB,CEO,CFO, 10%P - Purchase$0.25+3007,215,2560%+$74
DM
2020-03-27
VCNXVaccinex, Inc.Friedberg AlbertDir, 10%P - Purchase$4.11+9,0008,691,1220%+$37,020
2020-03-26
RYTMRhythm Pharmaceuticals, Inc.Foley ToddDirS - Sale$15.04-2,3002,359,4630%-$34,592
D
2020-03-26
EIDXEidos Therapeutics, Inc.Valle FrancoSVP, FinanceS - Sale+OE$48.26-5,0000-100%-$241,310
M
2020-03-26
EMMAEmmaus Life Sciences, Inc.Lee Willis CVice COB, COOP - Purchase$1.14+6,800319,885+2%+$7,770
M
2020-03-26
MYOVMyovant Sciences Ltd.Sumitomo Chemical Co., Ltd.10%P - Purchase$7.96+140,00046,648,6040%+$1,114,057
2020-03-27
ADILAdial Pharmaceuticals, Inc.Newman James W. Jr.DirP - Purchase$1.36+19,644269,732+8%+$26,769
2020-03-27
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$1.40+100,000220,162,3050%+$139,976
2020-03-26
PRPHProphase Labs, Inc.Gleckel Louis MdDirP - Purchase$1.75+100,000209,894+91%+$175,000
2020-03-26
PRPHProphase Labs, Inc.Karkus Ted WilliamCEO, COB, 10%S - Sale$1.75-100,0002,549,528-4%-$175,000
2020-03-25
IONSIonis Pharmaceuticals IncCrooke Stanley TExec COBS - Sale$47.00-16,000747,907-2%-$752,000
A
2020-03-17
IONSIonis Pharmaceuticals IncCrooke Stanley TExec COBS - Sale$44.75-20,000772,326-3%-$895,000
2020-03-26
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirS - Sale$46.03-11,5002,083,389-1%-$529,372
2020-03-26
MATNMateon Therapeutics IncTrieu VuongCEOP - Purchase$0.12+3,00019,893,5350%+$360
D
2020-03-26
UTHRUnited Therapeutics CorpGiltner RichardDirS - Sale+OE$91.75-5,0003,750-57%-$458,750
D
2020-03-27
ATNXAthenex, Inc.Lau Johnson Yiu NamCEO, COB, 10%P - Purchase$7.88+1,0004,063,9450%+$7,880
D
2020-03-27
ATNXAthenex, Inc.Sze RandollCFOP - Purchase$8.19+1,0005,000+25%+$8,190
2020-03-26
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$1.38+200,000220,062,3050%+$275,445
M
2020-03-25
ADILAdial Pharmaceuticals, Inc.Stilley William B. IIICEO, 10%P - Purchase$1.30+25,000715,937+4%+$32,552
2020-03-25
EPZMEpizyme, Inc.Beaulieu JosephCorporate ControllerS - Sale$15.28-2124,961-4%-$3,239
2020-03-25
EPZMEpizyme, Inc.Tombesi PaoloCFOS - Sale$15.28-1,24315,437-7%-$18,993
2020-03-25
EPZMEpizyme, Inc.Ros MatthewSee RemarksS - Sale$15.28-1,24351,798-2%-$18,993
D
2020-03-25
EPZMEpizyme, Inc.Bazemore Robert BPres, CEOS - Sale+OE$15.28-3,285254,371-1%-$50,195
2020-03-25
EPZMEpizyme, Inc.Agarwal ShefaliChief Medical OfficerS - Sale$15.28-1,24371,991-2%-$18,993
M
2020-03-24
BMRNBiomarin Pharmaceutical IncAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$76.18-3,65967,008-5%-$278,733
D
2020-03-24
EYENEyenovia, Inc.Ianchulev TsontchoCEO, 10%P - Purchase$2.27+82,4311,574,679+6%+$187,118
D
2020-03-24
EYENEyenovia, Inc.Mario ErnestDirP - Purchase$2.27+82,431327,239+34%+$187,118
DM
2020-03-24
VCNXVaccinex, Inc.Friedberg AlbertDir, 10%P - Purchase$4.41+3,0008,682,1220%+$13,240
D
2020-03-25
ATNXAthenex, Inc.Fok MansonDirP - Purchase$7.25+50,0002,755,670+2%+$362,500
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top